T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Advanced Micro Devices
AMD
$795B
| $5.78B | 0.52% |
40,201,028
-3,408,137
| -8% | -$458M |
|
27
Snap
SNAP
$8.91B
| $5.74B | 0.52% |
122,086,490
-17,607,412
| -13% | -$991M |
|
28
Stryker
SYK
$133B
| $5.66B | 0.51% |
21,156,776
-1,519,616
| -7% | -$399M |
|
29
Bank of America
BAC
$453B
| $5.6B | 0.5% |
125,923,671
-22,044,806
| -15% | -$1B |
|
30
HCA Healthcare
HCA
$89.7B
| $5.43B | 0.49% |
21,128,934
-257,102
| -1% | -$62.9M |
|
31
Roper Technologies
ROP
$38.9B
| $5.33B | 0.48% |
10,846,059
-405,430
| -4% | -$193M |
|
32
Atlassian
TEAM
$39B
| $5.32B | 0.48% |
13,939,775
+522,530
| +4% | +$210M |
|
33
AstraZeneca
AZN
$246B
| $5.23B | 0.47% |
44,920,376
+3,759,115
| +9% | +$442M |
|
34
Wells Fargo
WFC
$269B
| $5.12B | 0.46% |
106,813,994
-28,995,616
| -21% | -$1.43B |
|
35
Humana
HUM
$46.3B
| $4.87B | 0.44% |
10,508,002
+48,738
| +0.5% | +$21.6M |
|
36
Becton Dickinson
BDX
$49.7B
| $4.86B | 0.44% |
19,807,815
+3,981,547
| +25% | +$954M |
|
37
Yum! Brands
YUM
$40.6B
| $4.74B | 0.43% |
34,105,072
+2,415,909
| +8% | +$309M |
|
|
FISV
38
Fiserv Inc
FISV
$27.3B
| $4.65B | 0.42% |
44,832,098
-1,547,807
| -3% | -$160M |
|
39
Shopify
SHOP
$192B
| $4.58B | 0.41% |
33,245,950
+1,724,630
| +5% | +$252M |
|
40
Elevance Health
ELV
$86B
| $4.54B | 0.41% |
9,802,869
-20,557
| -0.2% | -$8.65M |
|
41
AbbVie
ABBV
$438B
| $4.41B | 0.4% |
32,585,913
+6,377,892
| +24% | +$753M |
|
42
American International
AIG
$39.9B
| $4.38B | 0.39% |
76,999,222
+1,387,749
| +2% | +$79M |
|
43
Dollar General
DG
$26.4B
| $4.37B | 0.39% |
18,522,760
+2,484,226
| +15% | +$549M |
|
44
Chubb
CB
$133B
| $4.36B | 0.39% |
22,571,047
+2,742,790
| +14% | +$515M |
|
|
MRSH
45
Marsh
MRSH
$90.1B
| $4.35B | 0.39% |
24,998,897
-2,977,369
| -11% | -$495M |
|
46
Cigna
CI
$73.4B
| $4.12B | 0.37% |
17,961,332
+597,424
| +3% | +$127M |
|
47
Booking.com
BKNG
$159B
| $4.1B | 0.37% |
42,726,375
+1,378,650
| +3% | +$131M |
|
48
PNC Financial Services
PNC
$102B
| $4.03B | 0.36% |
20,119,935
+561,343
| +3% | +$114M |
|
49
Nike
NKE
$60.4B
| $3.96B | 0.36% |
23,738,878
+82,831
| +0.4% | +$13.7M |
|
50
Walt Disney
DIS
$178B
| $3.93B | 0.35% |
25,365,085
-1,132,518
| -4% | -$183M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.